|

Epstein-Barr Virus and Cancer Risks

RECRUITINGSponsored by Sun Yat-sen University
Actively Recruiting
SponsorSun Yat-sen University
Started2008-08-01
Est. completion2024-12-31
Eligibility
Age30 Years – 69 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06203314

Summary

The goal of this prospective cohort study is to investigate the associations between Epstein-Barr Virus (EBV) antibody levels and the risk of overall and site-specific cancer types in Southern China. The main questions it aims to answer are: Question 1: In addition to the established EBV-associated cancer types, such as lymphomas, nasopharyngeal carcinoma, and stomach cancer, whether EBV is associated with other cancer types? Question 2: What's the cancer burden attributed to EBV in Southern China?

Eligibility

Age: 30 Years – 69 YearsHealthy volunteers accepted
Inclusion Criteria:

* Subject residents in Zhongshan or Wuzhou City;
* Subject has no medical record of prevalent cancer;
* Subject has psychical condition and well consciousness, and willingness to accept and cooperate with the study\'s follow-up procedures.

Exclusion Criteria:

* Subject has heavy cardiovascular, liver, or kidney disease;
* Subject has prevalent cancer.

Conditions1

Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.